Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15319774rdf:typepubmed:Citationlld:pubmed
pubmed-article:15319774lifeskim:mentionsumls-concept:C1527169lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0079459lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0229601lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:15319774lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:15319774pubmed:issue9lld:pubmed
pubmed-article:15319774pubmed:dateCreated2004-8-20lld:pubmed
pubmed-article:15319774pubmed:abstractTextA recent phase III trial comparing granulocyte colony-stimulating factor (G-CSF)-stimulated bone marrow (G-BM) and G-CSF-mobilized peripheral blood (G-PB) in matched sibling allograft recipients showed that G-BM produced a similar hematologic recovery but a reduced incidence of extensive chronic graft-versus-host disease, indicating differences in the cell populations infused. As a first step toward identifying these differences, we treated a group of healthy adult humans with 4 daily doses of G-CSF 10 microg/kg and monitored the effects on various hematopoietic and immune cell types in the PB and BM over 12 days. G-CSF treatment caused rapid and large but transient increases in the number of circulating CD34+ cells, colony-forming cells, and long-term culture-initiating cells and in the short-term repopulating activity detectable in nonobese diabetic/severe combined immunodeficiency/beta2-microglobulin-null mice. Similar but generally less marked changes occurred in the same cell populations in the BM. G-CSF also caused transient perturbations in some immune cell types in both PB and BM: these included a greater increase in the frequency of naive B cells and CD123+ dendritic cells in the BM. The rapidity of the effects of G-CSF on the early progenitor activity of the BM provides a rationale for the apparent equivalence in rates of hematologic recovery obtained with G-BM and G-PB allotransplants. Accompanying effects on immune cell populations are consistent with a greater ability of G-BM to promote tolerance in allogeneic recipients, and this could contribute to a lower rate of chronic graft-versus-host disease.lld:pubmed
pubmed-article:15319774pubmed:languageenglld:pubmed
pubmed-article:15319774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15319774pubmed:citationSubsetIMlld:pubmed
pubmed-article:15319774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15319774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15319774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15319774pubmed:statusMEDLINElld:pubmed
pubmed-article:15319774pubmed:monthSeplld:pubmed
pubmed-article:15319774pubmed:issn1083-8791lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:PanzarellaTon...lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:SchultzKirk...lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:GilmanAndrewAlld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:IssekutzAndre...lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:EavesConnie...lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:CoubanStephen...lld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:ImrenSuzanSlld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:SadekIreneIlld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:ShierLuke RLRlld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:ReganJillJlld:pubmed
pubmed-article:15319774pubmed:authorpubmed-author:LuoZhijuanZlld:pubmed
pubmed-article:15319774pubmed:issnTypePrintlld:pubmed
pubmed-article:15319774pubmed:volume10lld:pubmed
pubmed-article:15319774pubmed:ownerNLMlld:pubmed
pubmed-article:15319774pubmed:authorsCompleteYlld:pubmed
pubmed-article:15319774pubmed:pagination624-34lld:pubmed
pubmed-article:15319774pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:meshHeadingpubmed-meshheading:15319774...lld:pubmed
pubmed-article:15319774pubmed:year2004lld:pubmed
pubmed-article:15319774pubmed:articleTitleDifferential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors.lld:pubmed
pubmed-article:15319774pubmed:affiliationDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.lld:pubmed
pubmed-article:15319774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15319774pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15319774lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15319774lld:pubmed